3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Plasma cell
2
Conditions
Breast Neoplasms
68
Prostatic Neoplasms
44
Leukemia, Myeloid, Acute
35
Melanoma
34
Lung Neoplasms
28
Carcinoma, Non-Small-Cell Lung
28
Pancreatic Neoplasms
26
Myelodysplastic Syndromes
23
Multiple Myeloma
23
Colorectal Neoplasms
23
Leukemia, Lymphocytic, Chronic, B-Cell
22
Neoplasms
21
Squamous Cell Carcinoma of Head and Neck
19
Neoplasm Metastasis
19
Lymphoma, Large B-Cell, Diffuse
19
Rectal Neoplasms
16
Lymphoma, Mantle-Cell
14
Carcinoma, Renal Cell
14
Triple Negative Breast Neoplasms
13
Stomach Neoplasms
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Colonic Neoplasms
13
Lymphoma, Follicular
12
Uterine Cervical Neoplasms
11
Ovarian Neoplasms
11
Leukemia, Myelomonocytic, Chronic
11
Head and Neck Neoplasms
11
Esophageal Neoplasms
11
Myeloproliferative Disorders
10
Mouth Neoplasms
9
Interventions
Dexamethasone
16
Calcium Dobesilate
9
Melphalan
6
Lenalidomide
6
Cyclophosphamide
5
Bortezomib
5
pomalidomide
3
venetoclax
2
daratumumab
2
Thalidomide
2
Doxycycline
2
Biopsy
2
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
2
selinexor
1
pegfilgrastim
1
ixazomib
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
carfilzomib
1
belantamab mafodotin
1
auricularum
1
Vinorelbine
1
Technetium Tc 99m Pyrophosphate
1
Technetium
1
Tacrolimus
1
Surveys and Questionnaires
1
Interleukin-2
1
In Situ Hybridization, Fluorescence
1
In Situ Hybridization
1
Hyaluronoglucosaminidase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Amyloidosis
×
Biopsy
×
Clear all
NCT03886155
2021-12-22
CAST
The Cleveland Clinic
Completed
107 enrolled
NCT03923920
2021-12-22
ALF
The Cleveland Clinic
Completed
200 enrolled